Aspira Pathlab declares H1 FY27 Un-audited Financial Results

Aspira Pathlab & Diagnostics Ltd announced its un-audited standalone financial results for the second quarter and half-yearly ended September 30, 2026. The Board of Directors approved these results during a meeting held on November 06, 2026. The company also provided a Limited Review Report from its statutory auditor. The financial results are prepared in accordance with Indian Accounting Standard 34 and comply with SEBI (LODR) Regulations, 2015. A note highlights three summary suits filed against the company for premature termination of leave-and-licence agreements, amounting to ₹111.50 lakh plus interest and costs, with the outcome remaining uncertain and no provision made in the current results.